Zobrazeno 1 - 10
of 361
pro vyhledávání: '"P thor Straten"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/6ea7e42a647c4306a8434ed342d03af5
Autor:
Gitte Holmen Olofsson, Marta Kramer Mikkelsen, Anne-Mette Ragle, Anne Birgitte Christiansen, Anne Pries Olsen, Lise Heide-Ottosen, Cecilia Bech Horsted, Cia Moon Scharbau Pedersen, Lotte Engell-Noerregaard, Torben Lorentzen, Gitte Fredberg Persson, Anders Vinther, Dorte Lisbet Nielsen, Per thor Straten
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background The increasing role of exercise training in cancer care is built on evidence that exercise can reduce side effects of treatment, improve physical functioning and quality of life. We and others have shown in mouse tumor models, tha
Externí odkaz:
https://doaj.org/article/5e8927d4bda746018c5947287047c1a9
Autor:
Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Marlies J. W. Peeters, Aneta Radziwon-Balicka, Carlos Zamora, Tobias Wirenfeldt Klausen, Vibe Skov, Lasse Kjær, Christina Ellervik, Daniel El Fassi, Silvia Vidal, Hans Carl Hasselbalch, Mads Hald Andersen, Per thor Straten
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Myeloproliferative neoplasms (MPN) are chronic cancers of the hematopoietic stem cells in the bone marrow, and patients often harbor elevated numbers of circulating platelets (PLT). We investigated the frequencies of circulating PLT-lymphocyte aggreg
Externí odkaz:
https://doaj.org/article/4d831d41a2bb43238209bbff284b2564
Autor:
Marlies J. W. Peeters, Pia Aehnlich, Adriano Pizzella, Kasper Mølgaard, Tina Seremet, Özcan Met, Lene Juel Rasmussen, Per thor Straten, Claus Desler
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
T-cell activation upon antigen stimulation is essential for the continuation of the adaptive immune response. Impairment of mitochondrial oxidative phosphorylation is a well-known disruptor of T-cell activation. Dihydroorotate dehydrogenase (DHODH) i
Externí odkaz:
https://doaj.org/article/d07890576b8949e18e9b8caa7c3ef5cf
Autor:
Gitte Holmen Olofsson, Manja Idorn, Ana Micaela Carnaz Simões, Pia Aehnlich, Signe Koggersbøl Skadborg, Elfriede Noessner, Reno Debets, Bernhard Moser, Özcan Met, Per thor Straten
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The human Vγ9Vδ2 T cell is a unique cell type that holds great potential in immunotherapy of cancer. In particular, the therapeutic potential of this cell type in adoptive cell therapy (ACT) has gained interest. In this regard optimization of in vi
Externí odkaz:
https://doaj.org/article/f3c9003ba1074c3faf2c252ea6733a3b
Autor:
Shamaila Munir, Mia Thorup Lundsager, Mia Aabroe Jørgensen, Morten Hansen, Trine Hilkjær Petersen, Charlotte Menne Bonefeld, Christina Friese, Özcan Met, Per thor Straten, Mads Hald Andersen
Publikováno v:
Cell Stress, Vol 3, Iss 10, Pp 319-327 (2019)
PD-L1-specific T cells are a natural part of the T-cell repertoire in humans. Hence, we have previously described spontaneous CD8+ and CD4+ T-cell reactivity against PD-L1 in the peripheral blood of patients with various cancers as well as in healthy
Externí odkaz:
https://doaj.org/article/0ec72c78c2654d70964464228f0c9ac9
Autor:
Dorota E. Kuczek, Anne Mette H. Larsen, Marie-Louise Thorseth, Marco Carretta, Adrija Kalvisa, Majken S. Siersbæk, Ana Micaela C. Simões, Anne Roslind, Lars H. Engelholm, Elfriede Noessner, Marco Donia, Inge Marie Svane, Per thor Straten, Lars Grøntved, Daniel H. Madsen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-15 (2019)
Abstract Background Tumor progression is accompanied by dramatic remodeling of the surrounding extracellular matrix leading to the formation of a tumor-specific ECM, which is often more collagen-rich and of increased stiffness. The altered ECM of the
Externí odkaz:
https://doaj.org/article/a8b31eed6af14bd29e66f25eb8528c73
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/274467db7f8442a194c5276a07c1b35b
Autor:
Pia Aehnlich, Ana Micaela Carnaz Simões, Signe Koggersbøl Skadborg, Gitte Holmen Olofsson, Per thor Straten
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Cancer immunotherapy has shown great advances during recent years, but it has yet to reach its full potential in all cancer types. Adoptive cell therapy (ACT) is now an approved treatment option for certain hematological cancers and has also shown su
Externí odkaz:
https://doaj.org/article/757a48f776c54d8faaa89328f8bd179c
Autor:
Nadia Viborg, Sofie Ramskov, Rikke Sick Andersen, Theo Sturm, Tim Fugmann, Amalie Kai Bentzen, Vibeke Mindahl Rafa, Per thor Straten, Inge Marie Svane, Özcan Met, Sine Reker Hadrup
Publikováno v:
OncoImmunology, Vol 8, Iss 12 (2019)
Advances within cancer immunotherapy have fueled a paradigm shift in cancer treatment, resulting in increasing numbers of cancer types benefitting from novel treatment options. Despite originally being considered an immunologically silent malignancy,
Externí odkaz:
https://doaj.org/article/d65d998748ee418dbc7b1a27e99ea039